{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:20:45Z","timestamp":1794406845022,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","award":["ITCPD\/17-9"],"award-info":[{"award-number":["ITCPD\/17-9"]}],"id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["AoE\/M-401\/20"],"award-info":[{"award-number":["AoE\/M-401\/20"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,6,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The pervasive occurrence of nasopharyngeal carcinoma (NPC) is intricately linked to Epstein\u2013Barr virus (EBV) infection, making EBV and its associated pathways promising therapeutic targets for NPC and other EBV-related cancers. Lytic induction therapy, an emerging virus-targeted therapeutic strategy, capitalizes on the presence of EBV in tumor cells to specifically induce cytotoxicity against EBV-associated malignancies. Despite the expanding repertoire of compounds developed to induce EBV lytic reactivation, achieving universal induction across all infected cells remains elusive. The inherent heterogeneity of tumor cells likely contributes to this variability. In this study, we used the NPC43 cell line, an EBV-positive NPC in vitro model, and single-cell transcriptomics to characterize the diverse cellular responses to EBV lytic induction. Our longitudinal monitoring revealed a distinctive lytic induction non-responsive cellular state characterized by elevated expression of <jats:italic>SOX2<\/jats:italic> and <jats:italic>NTRK2<\/jats:italic>. Cells in this state exhibit phenotypic similarities to cancer stem cells (CSCs), and we verified the roles of <jats:italic>SOX2<\/jats:italic> and <jats:italic>NTRK2<\/jats:italic> in manifesting these phenotypes. Our findings reveal a significant challenge for lytic induction therapy, as not all tumor cells are equally susceptible. These insights highlight the importance of combining lytic induction with therapies targeting CSC-like properties to enhance treatment efficacy for NPC and other EBV-associated cancers.<\/jats:p>","DOI":"10.1038\/s41388-025-03341-z","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T01:01:44Z","timestamp":1742950904000},"page":"1805-1819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characterizing resistant cellular states in nasopharyngeal carcinoma during EBV lytic induction"],"prefix":"10.1038","volume":"44","author":[{"given":"Xinlei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-7651","authenticated-orcid":false,"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Tin-Yun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa Ming-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuk-Yu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Yung","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3488-6124","authenticated-orcid":false,"given":"Kwok-Wai","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3531-4830","authenticated-orcid":false,"given":"Angela Ruohao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"3341_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-1-23","volume":"1","author":"B Brennan","year":"2006","unstructured":"Brennan B. Nasopharyngeal carcinoma. Orphanet J Rare Dis. 2006;1:23.","journal-title":"Orphanet J Rare Dis"},{"key":"3341_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-016-0103-5","volume":"35","author":"H-Y Wang","year":"2016","unstructured":"Wang H-Y, Chang Y-L, To K-F, Hwang JSG, Mai H-Q, Feng Y-F, et al. A new prognostic histopathologic classification of nasopharyngeal carcinoma. Chin J Cancer. 2016;35:41.","journal-title":"Chin J Cancer"},{"key":"3341_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"KCW Wong","year":"2021","unstructured":"Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson D, Li L, et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol. 2021;18:679\u201395.","journal-title":"Nat Rev Clin Oncol"},{"key":"3341_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","volume":"387","author":"MLK Chua","year":"2016","unstructured":"Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387:1012\u201324.","journal-title":"Lancet"},{"key":"3341_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380.","journal-title":"Lancet"},{"key":"3341_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.oraloncology.2014.02.006","volume":"50","author":"SW Tsao","year":"2014","unstructured":"Tsao SW, Yip YL, Tsang CM, Pang PS, Lau VMY, Zhang G, et al. Etiological factors of nasopharyngeal carcinoma. Oral Oncol. 2014;50:330\u20138.","journal-title":"Oral Oncol"},{"key":"3341_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5732\/cjc.010.10377","volume":"30","author":"S-M Cao","year":"2011","unstructured":"Cao S-M, Simons MJ, Qian C-N. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer. 2011;30:114\u20139.","journal-title":"Chin J Cancer"},{"key":"3341_CR8","doi-asserted-by":"crossref","unstructured":"Young LS, Dawson CW. Epstein\u2013Barr virus and nasopharyngeal carcinoma. Chin J Cancer. 2014;33:581\u201390.","DOI":"10.5732\/cjc.014.10197"},{"key":"3341_CR9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41588-019-0436-5","volume":"51","author":"M Xu","year":"2019","unstructured":"Xu M, Yao Y, Chen H, Zhang S, Cao SM, Zhang Z, et al. Genome sequencing analysis identifies Epstein\u2013Barr virus subtypes associated with high risk of nasopharyngeal carcinoma. Nat Genet. 2019;51:1131\u20136.","journal-title":"Nat Genet"},{"key":"3341_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semcancer.2019.09.006","volume":"61","author":"CM Tsang","year":"2020","unstructured":"Tsang CM, Lui VWY, Bruce JP, Pugh TJ, Lo KW. Translational genomics of nasopharyngeal cancer. Semin Cancer Biol. 2020;61:84\u2013100.","journal-title":"Semin Cancer Biol"},{"key":"3341_CR11","doi-asserted-by":"publisher","unstructured":"Lin W, Yip YL, Jia L, Deng W, Zheng H, Dai W, et al. Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/S41467-018-06889-5.","DOI":"10.1038\/S41467-018-06889-5"},{"key":"3341_CR12","first-page":"121","volume":"83","author":"S Tim Cheung","year":"1999","unstructured":"Tim Cheung S, Huang DP, Hui AB, Wai KLO, Wai CK, Shan TSANG Y, et al. Nasopharyngeal carcinoma cell linE (C666-1) consistently harbouring Epstein\u2013Barr virus. J Cancer. 1999;83:121\u20136.","journal-title":"J Cancer"},{"key":"3341_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41374-018-0034-7","volume":"98","author":"YL Yip","year":"2018","unstructured":"Yip YL, Lin W, Deng W, Jia L, Lo KW, Busson P, et al. Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein\u2013Barr virus reactivation. Lab Investig. 2018;98:1093\u2013104.","journal-title":"Lab Investig"},{"key":"3341_CR14","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41422-020-0374-x","volume":"30","author":"YP Chen","year":"2020","unstructured":"Chen YP, Yin JH, Li WF, Li HJ, Chen DP, Zhang CJ, et al. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res. 2020;30:1024\u201342.","journal-title":"Cell Res"},{"key":"3341_CR15","doi-asserted-by":"publisher","unstructured":"Gong L, Kwong DLW, Dai W, Wu P, Li S, Yan Q, et al. Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/S41467-021-21795-Z.","DOI":"10.1038\/S41467-021-21795-Z"},{"key":"3341_CR16","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41422-020-00402-8","volume":"30","author":"S Jin","year":"2020","unstructured":"Jin S, Li R, Chen MY, Yu C, Tang LQ, Liu YM, et al. Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell Res. 2020;30:950\u201365.","journal-title":"Cell Res"},{"key":"3341_CR17","doi-asserted-by":"publisher","unstructured":"Liu Y, He S, Wang XL, Peng W, Chen QY, Chi DM, et al. Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/S41467-021-21043-4.","DOI":"10.1038\/S41467-021-21043-4"},{"key":"3341_CR18","doi-asserted-by":"publisher","unstructured":"Tay JK, Zhu C, Shin JH, Zhu SX, Varma S, Foley JW, et al. The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-\u03baB signaling. Sci Adv. 2022. https:\/\/doi.org\/10.1126\/SCIADV.ABH2445.","DOI":"10.1126\/SCIADV.ABH2445"},{"key":"3341_CR19","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.3390\/cancers12082142","volume":"12","author":"SPT Yiu","year":"2020","unstructured":"Yiu SPT, Dorothea M, Hui KF, Chiang AKS. Lytic induction therapy against Epstein\u2013Barr virus-associated malignancies: past, present, and future. Cancers. 2020;12:2142.","journal-title":"Cancers"},{"key":"3341_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14:275\u201391.","journal-title":"Cell Stem Cell"},{"key":"3341_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","volume":"24","author":"BC Prager","year":"2019","unstructured":"Prager BC, Xie Q, Bao S, Rich JN. Cancer stem cells: the architects of the tumor ecosystem. Cell Stem Cell. 2019;24:41\u201353.","journal-title":"Cell Stem Cell"},{"key":"3341_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cell.2009.08.017","volume":"138","author":"M Shackleton","year":"2009","unstructured":"Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009;138:822\u20139.","journal-title":"Cell"},{"key":"3341_CR23","doi-asserted-by":"publisher","first-page":"e52426","DOI":"10.1371\/journal.pone.0052426","volume":"7","author":"SWM Lun","year":"2012","unstructured":"Lun SWM, Cheung ST, Cheung PFY, To KF, Woo JKS, Choy KW, et al. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma. PLoS ONE. 2012;7:e52426.","journal-title":"PLoS ONE"},{"key":"3341_CR24","doi-asserted-by":"publisher","first-page":"44917","DOI":"10.18632\/oncotarget.16570","volume":"8","author":"EL Wuebben","year":"2017","unstructured":"Wuebben EL, Rizzino A, Wuebben EL, Rizzino A. The dark side of SOX2: cancer - a comprehensive overview. Oncotarget. 2017;8:44917\u201343.","journal-title":"Oncotarget"},{"key":"3341_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature13305","volume":"511","author":"S Boumahdi","year":"2014","unstructured":"Boumahdi S, Driessens G, Lapouge G, Rorive S, Nassar D, Le Mercier M, et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature. 2014;511:246\u201350.","journal-title":"Nature"},{"key":"3341_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep09979","volume":"5","author":"KC Chan","year":"2015","unstructured":"Chan KC, Chan LS, Ip JCY, Lo C, Yip TTC, Ngan RKC, et al. Therapeutic targeting of CBP\/\u03b2-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin. Sci Rep. 2015;5:1\u201312.","journal-title":"Sci Rep"},{"key":"3341_CR27","doi-asserted-by":"publisher","unstructured":"Zhang L, MacIsaac KD, Zhou T, Huang PY, Xin C, Dobson JR, et al. Genomic analysis of nasopharyngeal carcinoma reveals TME-based subtypes. Mol Cancer Res. 2017. https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0134.","DOI":"10.1158\/1541-7786.MCR-17-0134"},{"key":"3341_CR28","doi-asserted-by":"publisher","unstructured":"Schubert M, Klinger B, Kl\u00fcnemann M, Sieber A, Uhlitz F, Sauer S, et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-017-02391-6.","DOI":"10.1038\/s41467-017-02391-6"},{"key":"3341_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-019-1663-x","volume":"20","author":"FA Wolf","year":"2019","unstructured":"Wolf FA, Hamey FK, Plass M, Solana J, Dahlin JS, G\u00f6ttgens B, et al. PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells. Genome Biol. 2019;20:1\u20139.","journal-title":"Genome Biol"},{"key":"3341_CR30","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41592-024-02303-9","volume":"21","author":"P Weiler","year":"2024","unstructured":"Weiler P, Lange M, Klein M, Pe\u2019er D, Theis F. CellRank 2: unified fate mapping in multiview single-cell data. Nat Methods. 2024;21:1196\u2013205.","journal-title":"Nat Methods"},{"key":"3341_CR31","doi-asserted-by":"publisher","unstructured":"Gavish A, Tyler M, Greenwald AC, Hoefflin R, Simkin D, Tschernichovsky R, et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature. 2023. https:\/\/doi.org\/10.1038\/s41586-023-06130-4.","DOI":"10.1038\/s41586-023-06130-4"},{"key":"3341_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 2013;14:1\u201315.","journal-title":"BMC Bioinform"},{"key":"3341_CR33","doi-asserted-by":"publisher","unstructured":"Dekkers JF, Alieva M, Wellens LM, Ariese HCR, Jamieson PR, Vonk AM, et al. High-resolution 3D imaging of fixed and cleared organoids. Nat Protoc. 2019. https:\/\/doi.org\/10.1038\/s41596-019-0160-8.","DOI":"10.1038\/s41596-019-0160-8"},{"key":"3341_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-27150-6","volume":"12","author":"M B\u00fcttner","year":"2021","unstructured":"B\u00fcttner M, Ostner J, M\u00fcller CL, Theis FJ, Schubert B. scCODA is a Bayesian model for compositional single-cell data analysis. Nat Commun. 2021;12:1\u201310.","journal-title":"Nat Commun"},{"key":"3341_CR35","doi-asserted-by":"publisher","unstructured":"Yu L, Wang X, Mu Q, Tam SST, Loi DSC, Chan AKY, et al. scONE-seq: a single-cell multi-omics method enables simultaneous dissection of phenotype and genotype heterogeneity from frozen tumors. Sci Adv. 2023. https:\/\/doi.org\/10.1126\/SCIADV.ABP8901.","DOI":"10.1126\/SCIADV.ABP8901"},{"key":"3341_CR36","doi-asserted-by":"publisher","first-page":"e1005195","DOI":"10.1371\/journal.ppat.1005195","volume":"11","author":"DM Nawandar","year":"2015","unstructured":"Nawandar DM, Wang A, Makielski K, Lee D, Ma S, Barlow E, et al. Differentiation-dependent KLF4 expression promotes lytic Epstein-Barr virus infection in epithelial cells. PLoS Pathog. 2015;11:e1005195.","journal-title":"PLoS Pathog"},{"key":"3341_CR37","doi-asserted-by":"publisher","unstructured":"Kazanietz MG, Cooke M. Protein kinase C signaling \u201cin\u201d and \u201cto\u201d the nucleus: master kinases in transcriptional regulation. J Bioll Chem. 2024. https:\/\/doi.org\/10.1016\/j.jbc.2024.105692.","DOI":"10.1016\/j.jbc.2024.105692"},{"key":"3341_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1407-6","volume":"10","author":"CFA Warren","year":"2019","unstructured":"Warren CFA, Wong-Brown MW, Bowden NA. BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis. 2019;10:1\u201312.","journal-title":"Cell Death Dis"},{"key":"3341_CR39","doi-asserted-by":"publisher","first-page":"188569","DOI":"10.1016\/j.bbcan.2021.188569","volume":"1876","author":"L Zhang","year":"2021","unstructured":"Zhang L, Lu Z, Zhao X. Targeting Bcl-2 for cancer therapy. Bioch Biophys Acta Rev Cancer. 2021;1876:188569.","journal-title":"Bioch Biophys Acta Rev Cancer"},{"key":"3341_CR40","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1128\/JVI.02175-10","volume":"85","author":"AJ Rennekamp","year":"2011","unstructured":"Rennekamp AJ, Lieberman PM. Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt. J Virol. 2011;85:2837\u201350.","journal-title":"J Virol"},{"key":"3341_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"3341_CR42","doi-asserted-by":"publisher","unstructured":"Zhu Y, Huang S, Chen S, Chen J, Wang Z, Wang Y, et al. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by \u03b2-catenin and Beclin1\/autophagy signaling in colorectal cancer. Cell Death Dis. 2021. https:\/\/doi.org\/10.1038\/S41419-021-03733-5.","DOI":"10.1038\/S41419-021-03733-5"},{"key":"3341_CR43","doi-asserted-by":"publisher","unstructured":"Singh S, Trevino J, Bora-Singhal N, Coppola D, Haura E, Altiok S, et al. EGFR\/Src\/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer. 2012. https:\/\/doi.org\/10.1186\/1476-4598-11-73.","DOI":"10.1186\/1476-4598-11-73"},{"key":"3341_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0074-2","volume":"7","author":"J Tang","year":"2018","unstructured":"Tang J, Zhong G, Wu J, Chen H, Jia Y. SOX2 recruits KLF4 to regulate nasopharyngeal carcinoma proliferation via PI3K\/AKT signaling. Oncogenesis. 2018;7:61.","journal-title":"Oncogenesis"},{"key":"3341_CR45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.mcn.2008.07.024","volume":"39","author":"H Kumanogoh","year":"2008","unstructured":"Kumanogoh H, Asami J, Nakamura S, Inoue T. Balanced expression of various TrkB receptor isoforms from the Ntrk2 gene locus in the mouse nervous system. Mol Cell Neurosci. 2008;39:465\u201377.","journal-title":"Mol Cell Neurosci"},{"key":"3341_CR46","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018;15:731\u201347.","journal-title":"Nat Rev Clin Oncol"},{"key":"3341_CR47","doi-asserted-by":"publisher","unstructured":"Pattwell SS, Arora S, Nuechterlein N, Zager M, Loeb KR, Cimino PJ, et al. Oncogenic role of a developmentally regulated NTRK2 splice variant. Sci Adv. 2022. https:\/\/doi.org\/10.1126\/SCIADV.ABO6789.","DOI":"10.1126\/SCIADV.ABO6789"},{"key":"3341_CR48","doi-asserted-by":"publisher","unstructured":"Pattwell SS, Arora S, Cimino PJ, Ozawa T, Szulzewsky F, Hoellerbauer P, et al. A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/S41467-020-16786-5.","DOI":"10.1038\/S41467-020-16786-5"},{"key":"3341_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1006\/viro.1993.1597","volume":"197","author":"C Cochet","year":"1993","unstructured":"Cochet C, Martel-Renoir D, Grunewald V, Bosq J, Cochet G, Schwaab G, et al. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology. 1993;197:358\u201365.","journal-title":"Virology"},{"key":"3341_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20:74\u201388.","journal-title":"Nat Rev Cancer"},{"key":"3341_CR51","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21:607\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3341_CR52","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41388-019-0997-x","volume":"39","author":"T Schaefer","year":"2020","unstructured":"Schaefer T, Lengerke C. SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K\/AKT\/SOX2 axis and beyond. Oncogene. 2020;39:278\u201392.","journal-title":"Oncogene"},{"key":"3341_CR53","first-page":"2141","volume":"144","author":"S Haston","year":"2017","unstructured":"Haston S, Pozzi S, Carreno G, Manshaei S, Panousopoulos L, Gonzalez-Meljem JM, et al. MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma. Development. 2017;144:2141\u201352.","journal-title":"Development"},{"key":"3341_CR54","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","volume":"573","author":"V Padmanaban","year":"2019","unstructured":"Padmanaban V, Krol I, Suhail Y, Szczerba BM, Aceto N, Bader JS, et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019;573:439\u201344.","journal-title":"Nature"},{"key":"3341_CR55","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonz\u00e1lez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: Single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083\u20136.","journal-title":"Nat Methods"},{"key":"3341_CR56","doi-asserted-by":"publisher","unstructured":"Wang X, Xu Z, Chen X, Ren X, Wei J, Zhou S, et al. A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma. PeerJ. 2019. https:\/\/doi.org\/10.7717\/PEERJ.7125\/SUPP-1.","DOI":"10.7717\/PEERJ.7125\/SUPP-1"},{"key":"3341_CR57","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1038\/s41388-024-03165-3","volume":"43","author":"Y Mu","year":"2024","unstructured":"Mu Y, Wallenius A, Zang G, Zhu S, Rudolfsson S, Aripaka K, et al. The T\u03b2RI promotes migration and metastasis through thrombospondin 1 and ITGAV in prostate cancer cells. Oncogene. 2024;43:3321\u201334.","journal-title":"Oncogene"},{"key":"3341_CR58","first-page":"211","volume":"10","author":"IW-Y Cheuk","year":"2020","unstructured":"Cheuk IW-Y, Siu MT, Ho JC-W, Chen J, Shin VY, Kwong A. ITGAV targeting as a therapeutic approach for treatment of metastatic breast cancer. Am J Cancer Res. 2020;10:211.","journal-title":"Am J Cancer Res"},{"key":"3341_CR59","first-page":"1","volume":"15","author":"M Wu","year":"2024","unstructured":"Wu M, Hau PM, Li L, Tsang CM, Yang Y, Taghbalout A, et al. Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nat Commun. 2024;15:1\u201318.","journal-title":"Nat Commun"},{"key":"3341_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-020-1946-0","volume":"578","author":"JB McBrien","year":"2020","unstructured":"McBrien JB, Mavigner M, Franchitti L, Smith SA, White E, Tharp GK, et al. Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells. Nature. 2020;578:154\u20139.","journal-title":"Nature"},{"key":"3341_CR61","doi-asserted-by":"publisher","unstructured":"Zheng R, Wan C, Mei S, Qin Q, Wu Q, Sun H, et al. Cistrome Data Browser: Expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019. https:\/\/doi.org\/10.1093\/nar\/gky1094.","DOI":"10.1093\/nar\/gky1094"},{"key":"3341_CR62","doi-asserted-by":"publisher","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The Human Genome Browser at UCSC. Genome Res. 2002. https:\/\/doi.org\/10.1101\/gr.229102.","DOI":"10.1101\/gr.229102"},{"key":"3341_CR63","doi-asserted-by":"publisher","unstructured":"Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, Kirkup VM, et al. ENCODE Data in the UCSC Genome Browser: Year 5 update. Nucleic Acids Res. 2013. https:\/\/doi.org\/10.1093\/nar\/gks1172.","DOI":"10.1093\/nar\/gks1172"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03341-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03341-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03341-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:03:18Z","timestamp":1749236598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03341-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":63,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,6,30]]}},"alternative-id":["3341"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03341-z","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the \u201cChapter 9: Biological Safety\u201d guidelines and regulations at HKUST. Written patient consents were obtained from all patients in this study according to institutional clinical research approval. The study protocol (2013.229) was approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee at the Chinese University of Hong Kong, Hong Kong SAR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}